in 50 mM Hepes buffer (pH 7.0) using 7–12 μM R67 DHFR
with addition of 5 mM 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide
(EDC) and either 0.07–2 mM folate or 640 μM DHF.3 (link) NADPH (1 mM) was added to determine if it could
protect the active site from modification. Inactivation rates were
calculated using a fit to a single exponential with a linear rate.
The stoichiometry of EDC labeling was determined using samples
inactivated to <10% remaining activity. Depending on the folate
concentration and the enzyme species used, this could require an overnight
incubation. The reaction was quenched by addition of ammonium chloride
or Tris buffer. Unreacted folate was removed by passing the solution
over a DEAE-fractogel column (Supelco, 11 cm × 1.5 cm) equilibrated
in 10 mM Tris and 1 mM EDTA (pH 8.0) or an epifuge spin column loaded
with small amounts of this resin. For reactions using a His-tagged
R67 DHFR construct, a His Spintrap column (GE Healthcare) was used
to separate the labeled protein from unreacted folate. Protein concentrations
were monitored by a BCA assay, while folate concentrations were measured
by absorbance at 350 nm with an extinction coefficient of 7000 mol–1 cm–1.25 (link)